When is diabetes mellitus a relative or absolute contraindication to liver transplantation?

Liver Transplantation

Volumn 11, Issue 11 SUPPL. 2, 2005, Pages

  Thuluvath, Paul J ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; INSULIN;

ANGIOCARDIOGRAPHY; ARTICLE; AUTONOMIC NEUROPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM EXAMINATION; COMORBIDITY; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE SEVERITY; HEART LEFT VENTRICLE FUNCTION; HUMAN; INFECTION; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MORBID OBESITY; MORBIDITY; OBESITY; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STOMACH PARESIS; SURGICAL TECHNIQUE; SURVIVAL TIME; TREATMENT CONTRAINDICATION;

CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; KIDNEY FAILURE, CHRONIC; LIVER TRANSPLANTATION; OBESITY, MORBID; RISK FACTORS;

EID: 30444455636     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20606     Document Type: Article

References (45)

1. Petrides AS, Schulze-Berge D, Vogt C, Matthews DE, Strohmeyer G. Glucose resistance contributes to diabetes mellitus in cirrhosis. Hepatology 1993;18:284-291.
2. Muller MJ, Willman O, Rieger A, Fenk A, Selberg O, Lautz HU, et al. Mechanism of insulin resistance associated with liver cirrhosis. Gastroenterology 1992;102:2033-2041.
3. Petrides AS, Vogt C, Schulze-Berge D, Matthews DE, Strohmeyer G. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 1994;19:616-627.
4. Navasa M, Bustamante J, Marroni C, Gonzalez E, Andreu H, Esmatjes E, et al. Diabetes after liver transplantation: prevalence and predictive factors. J Hepatol 1996;25:64-71.
5. Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol 2000;32:209-217.
6. Bigam DL, Pennington JJ, Carpentier A, Wanless IR, Hemming AW, Croxford R, et al. Hepatitis C-related cirrhosis: a predictor of diabetes after liver transplantation. Hepatology 2000;32:87-90.
7. Delgado-Borrego A, Casson D, Schoenfeld D, Somsouk M, Terella A, Jordan SH, et al. Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation 2004;77:703-10.
8. Ost L, Tyden G, Fehrman I. Impaired Glucose Tolerance in Cyclosporine prednisolone treated renal graft recipients. Transplantation 1988;46:370-372.
9. Roth D, Milgrom M, Esquenazi V, Fuller L, Burke G, Miller J. Post transplant hyperglycemia; increased incidence in cyclosporine treated renal allograft recipients. Transplantation 1989;47:278-281.
10. Boudreaux JP, McHugh L, Canafax DM, Ascher N, Sutherland DF, Payne W, et al. The impact of cyclosporine and combination immunosuppression on the incidence of post-transplant diabetes in renal allograft recipients. Transplantation 1987;44:376-381.
11. Rao KV, Anderson RC. The impact of diabetes on vascular complications following cadaver renal transplantation. Transplantation 1987;43:193-197.
12. Rischen-Vos J, van der Woude FJ, Tegzess AM, Zwinderman AH, Gooszen HC, van den Akker PJ, van Es LA. Increased morbidity and mortality in patients with diabetes mellitus after kidney transplantation as compared with non-diabetic patients. Nephron Dial Transplant 1992;7:433-437.
13. www.cdc.gov/diabetes
14. Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes with cryptogenic cirrhosis: a case-control study. Hepatology 2000;32:689-692.
15. Trail KC, Stratta RJ, Larsen JL, Ruby EI, Patil KD, Langnas AN, et al. Results of liver transplantation in diabetic recipients. Surgery 1993;114:650-656.
16. Blanco JJ, Herrero JI, Quiroga J, Sangro B, Gómez-Manero N, Pardo F, et al. Liver transplantation in cirrhotic patients with diabetes mellitus: mid-term results, survival, and adverse events. Liver Transpl 2001;7:226-233.
17. Shields PL, Tang H, Neuberger JM, Gunson BK, McMaster P, Pirenne J. Poor outcome in patients with diabetes mellitus undergoing liver transplantation. Transplantation 1999;68:530-535.
18. John PR, Thuluvath PJ. Outcome of liver transplantation in patients with diabetes mellitus: a case-control study. Hepatology 2001;34:889-895.
19. Yoo HY, Thuluvath PJ. The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation. Transplantation 2002;7:1007-1012.
20. Ashton CM, Petersen NJ, Wray NP, Kiefe CI, Dunn JK, Wu L, Thomas JM. The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med 1993;118:504-510.
21. Kumar R, McKinney WP, Raj G, Heudebert GR, Heller HJ, Koetting M, McIntire DD. Adverse cardiac events after surgery: assessing risk in a veteran population. J Gen Intern Med 2001;16:507-518.
22. Plotkin JS, Scott VL, Pinna A, Dobsch BP, DeWolf AM, Kang Y. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg 1996;2:426-430.
23. Pruthi J, Medkiff KA, Esrason KT, Donovan JA, Yoshida EM, Erb SR, et al. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl 2001;7:811-15.
24. Keefe BG, Valantine H, Keeffe EB. Detection and treatment of coronary artery disease in liver transplant candidates. Liver Transpl 2001;7:7557-7561.
25. Enbergs A, Bürger R, Reinecke H, Borggrefe M, Breithardt G, Kerber S. Prevalence of coronary artery disease in a general population without suspicion of coronary artery disease: angiographic analysis of subjects aged 40 to 70 years referred for catheter ablation therapy. Eur Heart J 2000;21:45-52.
26. Carey WD, Dumot JA, Pimentel RR, Barnes DS, Hobbs RE, Henderson JM, et al. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 1995;59:859-864.
27. Ramanathan V, Goral S, Tanriover B, Feurer ID, Kazancioglu R, Shaffer D, Helderman JH. Screening asymptomatic diabetic patients for coronary artery disease prior to renal transplantation. Transplantation 2005;79:1453-1458.
28. Nair S, Cohen DB, Cohen C, Tan H, Maley W, Thuluvath PJ. Postoperative morbidity, mortality, costs, and long-term survival in severely obese patients undergoing orthotopic liver transplantation. Am J Gastroenterol 2001;96:842-845.
29. Nair S, Verma S, and Thuluvath PJ. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology 2002;35:105-109.
30. Pawarode A, Fine DM, Thuluvath PJ. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl 2003;9:741-747.
31. Valmadrid CT, Klein R, Moss SE, Klein BE. The risk of cardiovascular disease mortality with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 2000;160:1093-1100.
32. Fraley DS, Burr R, Bernardini J, Angus D, Kramer DJ, Johnson JP. Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation. Kidney Int 1998;54:518-524.
33. Lafayette RA, Paré G, Schmid CH, King AJ, Rohrer RJ, Nasraway SA. Pretransplant renal dysfunction predicts poorer outcome in liver transplantation. Clin Nephrol 1997;48:159-164.
34. Qian YB, Cheng GH, Huang JF. Multivariate regression analysis on early mortality after orthotopic liver transplantation. World J Gastroenterol 2002;8:128-130.
35. Baliga P, Merion RM, Turcotte JG, Ham JM, Henley KS, Lucey MR, et al. Preoperative risk factor assessment in liver transplantation. Surgery 1992;112:704-710.
36. Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS. Impact of pretransplant renal function on survival after liver transplantation. Transplantation 1995;59:361-365.
37. McCauley J, Van Thiel DH, Starzl TE, Puschett JB. Acute and chronic renal failure in liver transplantation. Nephron 1990;55:121-128.
38. Moreau R, Leberc D. Acute renal failure in patients with cirrhosis: perspective in the age of MELD. Hepatology 2003;37:233-243.
39. Nair S, Verma S, and Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002;35:1179-1185.
40. Thuluvath PJ, Yoo HY, Thompson RE. A model to predict survival at one month, one year, and five years after liver transplantation based on pretransplant clinical characteristics. Liver Transpl 2003;9:527-532.
41. Klein R, Klein BE, Moss SE, Cruickshanks KJ. Association of ocular disease and mortality in a diabetic population. Arch Opthalmol 1999;117:1487-1495.
42. Scheen AJ, Warzee F. Diabetes is still a risk factor for restenosis after drug-eluting stent in coronary arteries. Diabetes Care 2004;27:1840-1841.
43. Eisenberg B, Murata GH, Tzamaloukas AH, Zager PG, Avasthi PS. Gastroparesis in diabetics on chronic dialysis: clinical and laboratory association and predictive features. Nephron 1995;70:296-300.
44. Kong MF, Horowitz M, Jones KL, Wishart JM, Harding PE. Natural history of diabetic gastroparesis. Diabetes Care 1999;22:503-507.
45. Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries FA. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 1993;10:820-824.